These Three Toilet Detection Health Technology Will Be In The United States, イスラエル, Japan Clinical Trials

キッチンとバスルーム業界の主流メディア キッチンとバスルームの情報

Israeli digital health startup OutSense was awarded a number of key innovation patents for IoT technology, foreign media reported on June 23. The technology gains life-saving medical insights by analyzing human excrement. 同社は、医療用トイレセンサーの要素をカバーする一連の3つの特許を提出しました.

The first OutSense patent is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet bowl to determine the optical signature of hidden blood in feces. Patents for this technology have been granted in the United States, ヨーロッパ, 日本と中国. A second patent has been granted in Europe and applications are pending for this patent in other countries. It allows effective analysis of the spatial distribution of the many components of stool and traces of blood. Based on this analysis, Autsenseのテクノロジーは、胃腸管に沿った血液源を識別できます. A third patent is pending for the technology, which detects urine dehydration components by analyzing urine and feces.

アウトセイブCEOのYfat Scialomによると, he predicts that “デジタル医学の爆発で. This kind of monitoring will become the norm.” OutSense says the technology, which has already been approved and is pending approval, will provide broad protection for a person’s health by non-invasively extracting hidden blood from feces and urine. Hidden blood is critical for detecting colorectal cancer, 炎症性腸疾患および尿路感染症. Its solution includes a multispectral optical sensor, WiFi接続を含む光源と自律スクリーニングデバイス. The device scans human feces and identifies the optical footprint of fecal and urine components. It sends the data to an artificial intelligence-based cloud analysis, which then provides signs of various diseases with great precision.

OutSense develops tools to diagnose abnormalities in human feces. サンプリングされた血液から得られた情報, 出血から排泄までの時間の追加分析と組み合わされて, 出血病理学の詳細を提供します. Its specific patterns can determine whether the bleeding is from a fissure or hemorrhoid, or from a polyp, tumor or from an ulcer. In early June, アウトエンスはそのcommunicareを発表しました, それ以上の大規模な医療会社 90 medical facilities in the United States, 今年、技術の操縦を開始します. このパイロットに加えて, OutSense plans to conduct clinical trials in Israel and Japan.